Anxiety, Uncooperation in Pediatric Dental Treatment. Phobic anxiety disorder of childhood
Conditions
Interventions
Intervention: PO midazolam 2.5 mg/ml
Control: mdazolam surup Amsed 2.5 mg/ml.
Treatment - Drugs
Intervention: PO midazolam 2.5 mg/ml
Control: mdazolam surup Amsed 2.5 mg/ml
Sponsors
Guilan University of Medical Sciences, Deputy of Research and Technology
Eligibility
Sex/Gender
All
Age
4 Years to 6 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Uncooperative behavior (Frankl 1,2); age 4 to 6 years; ASA I Exclusion criteria: Hypertrophic tonsils /adenoids (Brodsky>2); weight >24 kg; History of allergy to Benzodiazepines; Sleep apnea; history of common cold/ Respiratory disease during the past two weeks.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation. Timepoint: Sedation: At the time of injection, cavity preparation and restoration. Method of measurement: By the means of North Carolina Behavior Rting Scale.;Physiological parameters(Systoic and diastolic Blood pressure), Heart rate, Respiratory rate, SPO2. Timepoint: Before drug administration, at the onset of treatment, and then every 15 minutes. Method of measurement: Blood pressure:Digital blood pressure cuff,Heart rate: pulse oximeter, Respiratory rate: counting the breathing movements of thorax, SPO2: Pulseoximeter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dental fear, General Anxiety, Child's personality (different aspects). Timepoint: Before treatment. Method of measurement: Questionnaires: CFSS-DS, SDQ, Conner's parental rating scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKatayoun Salem
Guilan Dental School
Outcome results
None listed